Connective tissue diseases: A nonsurgical therapy for Dupuytren disease

Nature Reviews Rheumatology

Volumn 6, Issue 1, 2010, Pages 7-8

  Bayat, Ardeshir ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; CLOSTRIDIOPEPTIDASE A; CORTICOSTEROID; INTERFERON; OXYGEN; PLACEBO;

CLINICAL EFFECTIVENESS; CLINICAL STUDY; CLINICAL TRIAL; COMPLEX REGIONAL PAIN SYNDROME; CONNECTIVE TISSUE DISEASE; CONSERVATIVE TREATMENT; DUPUYTREN CONTRACTURE; FASCIOTOMY; HAND DISEASE; HUMAN; HYPERBARIC OXYGEN; PHYSIOTHERAPY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECURRENT DISEASE; SHORT SURVEY; SOCIAL SUPPORT; SPLINTING; SWELLING; TENDON RUPTURE; TREATMENT OUTCOME; ULTRASOUND THERAPY;

CLINICAL TRIALS, PHASE III AS TOPIC; DUPUYTREN CONTRACTURE; HUMANS; INJECTIONS, INTRA-ARTICULAR; MICROBIAL COLLAGENASE;

EID: 75149131792     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2009.255     Document Type: Short Survey

References (9)

1. Bayat, A. & McGrouther, D. A. Management of Dupuytren's disease-clear advice for an elusive condition. Ann. R. Coll. Surg. Engl. 88, 3-8 (2006).
2. Bayat, A., Cunliffe, E. J. & McGrouther, D. A. Assessment of clinical severity in Dupuytren's disease. Br. J. Hosp. Med. (Lond.) 68, 604-609 (2007).
3. Hindocha, S., John, S., Stanley, J. K., Watson, S. J. & Bayat, A. The heritability of Dupuytren's disease: familial aggregation and its clinical significance. J. Hand Surg. Am. 31, 204-210 (2006).
4. Hindocha, s., stanley, J. K., watson, s. & Bayat, A. Dupuytren's diathesis revisited: evaluation of prognostic indicators for risk of disease recurrence. J. Hand Surg. Am. 31, 1626-1634 (2006).
5. Hurst, L. C. & Badalamente, M. A. Nonoperative treatment of Dupuytren's disease. Hand Clin. 15, 97-107 (1999).
6. Badalamente, M. A. & Hurst, L. C. Enzyme injection as nonsurgical treatment of Dupuytren's disease. J. Hand Surg. Am. 25, 629-636 (2000).
7. Badalamente, M. A., Hurst, L. C. & Hentz, v. R. Collagen as a clinical target: nonoperative treatment of Dupuytren's disease. J. Hand Surg. Am. 27, 788-798 (2002).
8. Badalamente, M. A. & Hurst, L. C. Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren's contracture. J. Hand Surg. Am. 32, 767-774 (2007).
9. Hurst, L. C. et al. injectable collagenase clostridium histolyticum for Dupuytren's contracture. N. Engl. J. Med. 361, 968-979 (2009).